Prevention of surgical site infections

Expert Review of Anti-Infective Therapy

Volumn 4, Issue 2, 2006, Pages 223-233

  Hedrick, Traci L ^a   Anastacio, Melissa M ^a   Sawyer, Robert G ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Antibiotic; Prevention; Prophylaxis; Surgery; Surgical site infection

Indexed keywords

2 PROPANOL; ALCOHOL; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFAZOLIN; CEFOTETAN; CEFOXITIN; CEPHALOSPORIN; CHLORHEXIDINE; CLINDAMYCIN; ERTAPENEM; GLUCOSE; INSULIN; IODINE; IODOPHOR; METICILLIN; METRONIDAZOLE; NAFCILLIN; OXACILLIN; OXYGEN; PENICILLIN G; POVIDONE IODINE; PROPANOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SOAP; UNINDEXED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ASEPSIS; BATH; CIGARETTE SMOKING; DRUG CHOICE; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRY SKIN; ENTEROCOCCUS; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI; EVIDENCE BASED PRACTICE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAND WASHING; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH STATUS; HOSPITAL READMISSION; HUMAN; HYPERGLYCEMIA; HYPOTHERMIA; INCIDENCE; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL CONTAMINATION; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; NUTRITIONAL STATUS; OPERATION DURATION; OXYGEN THERAPY; PATHOPHYSIOLOGY; PREOPERATIVE CARE; PROPHYLAXIS; PROTECTIVE CLOTHING; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SKIN IRRITATION; SMOKING CESSATION; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; SURGICAL PATIENT; SURGICAL TECHNIQUE; TIME; TREATMENT INDICATION; WARMING; WOUND CARE; WOUND HEALING;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; HUMANS; INFECTION CONTROL; METHICILLIN RESISTANCE; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 33646185418     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.4.2.223     Document Type: Review

References (113)

1. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect. Control Hosp. Epidemiol. 13(10), 606-608 (1992).
2. Horan TC, Culver DH, Gaynes RP, Jarvis WR, Edwards JR, Reid CR. Nosocomial infections in surgical patients in the United States, January 1986-June 1992. National Nosocomial Infections Surveillance (NNIS) System. Infect. Control Hosp. Epidemiol. 14(2), 73-80 (1993).
3. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect. Control Hosp. Epidemiol. 20(11), 725-730 (1999):
4. Martone WJ. Hospital Infections. Lippencott-Raven, PA, USA (1998).
5. Berard F, Gandon J. Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and of various other factors. Ann. Surg. 160(Suppl. 1), 1-192 (1964).
6. Cruse PJ, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg. Clin. North Am. 60(1), 27-40 (1980).
7. Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am. J. Epidemiol. 121(2), 206-215 (1985).
8. Culver DH, Horan TC, Gaynes RP et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am. J. Med. 91(3B), 152S-157S (1991).
9. Delgado-Rodriguez M, Sillero-Arenas M, Medina-Cuadros M, Martinez-Gallego G. Nosocomial infections in surgical patients: comparison of two measures of intrinsic patient risk. Infect. Control Hosp. Epidemiol. 18(1), 19-23 (1997).
10. Garibaldi RA, Cushing D, Lerer T. Risk factors for postoperative infection. Am. J. Med. 91(3B), 158S-163S (1991).
11. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am. J. Infect. Control 27(2), 97-132 (1999).
12. Nagachinta T, Stephens M, Reitz B, Polk BF. Risk factors for surgical-wound infection following cardiac surgery. J. Infect Dis. 156(6), 967-973 (1987).
13. Emori TG, Banerjee SN, Culver DH et al. Nosocomial infections in elderly patients in the United States, 1986-1990. National Nosocomial Infections Surveillance System. Am. J. Med. 91(3B), 289S-293S (1991).
14. Kaye KS, Schmit K, Pieper C et al. The effect of increasing age on the risk of surgical site infection. J. Infect. Dis. 191(7), 1056-1062 (2005).
15. Raymond DP, Pelletier SJ, Crabtree TD, Schulman AM, Pruett TL, Sawyer RG. Surgical infection and the aging population. Am. Surg. 67(9), 827-832 (2001).
16. Kaye KS, Schmader KE, Sawyer R. Surgical site infection in the elderly population. Clin. Infect. Dis. 39(12), 1835-1841 (2004).
17. Fietsam R Jr, Bassett J, Glover JL. Complications of coronary artery surgery in diabetic patients. Am. Surg. 57(9), 551-557 (1991).
18. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect. Control Hosp. Epidemiol. 22(10), 607-612 (2001).
19. Choban PS, Heckler R, Burge JC, Flancbaum L. Increased incidence of nosocomial infections in obese surgical patients. Am. Surg. 61(11), 1001-1005 (1995).
20. Smith RL, Bohl JK, McElearney ST et al. Wound infection after elective colorectal resection. Ann. Surg. 239(5), 599-605 (2004).
21. Kabon B, Nagele A, Reddy D et al. Obesity decreases perioperative tissue oxygenation. Anesthesiology 100(2), 274-280 (2004).
22. Allen DB, Maguire JJ, Mahdavian M et al. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch. Surg. 132(9), 991-996 (1997).
23. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N. Engl. J. Med. 334(19), 1209-1215 (1996).
24. Gottrup F, Firmin R, Rabkin J, Halliday BJ, Hunt TK. Directly measured tissue oxygen tension and arterial oxygen tension assess tissue perfusion. Crit. Care Med. 15(11), 1030-1036 (1987).
25. Hopf HW, Hunt TK, West JM et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch. Surg. 132(9), 997-1004 (1997).
26. Darouiche RO. Treatment of infections associated with surgical implants. N. Engl. J. Med. 350(14), 1422-1429 (2004).
27. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6(4), 428-442 (1993).
28. Nichols RL. Current strategies for prevention of surgical site infections. Curr. Infect. Dis. Rep. 6(6), 426-434 (2004).
29. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32(8), 470-485 (2004).
30. Engemann JJ, Carmeli Y, Cosgrove SE et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis. 36(5), 592-598 (2003).
31. Padubidri AN, Yetman R, Browne E et al. Complications of postmastectomy breast reconstructions in smokers, ex-smokers, and nonsmokers. Plast. Reconstr. Surg. 107(2), 342-349 (2001).
32. Kueger JK, Rohrich RJ. Clearing the smoke: the scientific rationale for tobacco abstention with plastic surgery. Plast. Reconstr. Surg. 108(4), 1063-1073 (2001).
33. Manassa EH, Hertl CH, Olbrisch RR. Wound healing problems in smokers and nonsmokers after 132 abdominoplasties. Plast. Reconstr. Surg. 111 (6), 2082-2087 (2003).
34. Moller AM, Villebro N, Pedersen T, Tonnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 359(9301), 114-117 (2002).
35. Fan ST Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N. Engl. J. Med. 331(23), 1547-1552 (1994).
36. Muller JM, Brenner U, Dienst C, Pichlmaier H. Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet 1(8263), 68-71 (1982).
37. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N. Engl. J. Med. 325 (8), 525-532 (1991).
38. Brennan MF, Pisters PW, Posner M, Quesada O, Shike M. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann. Surg. 220(4), 436-441 (1994).
39. Shukla HS, Rao RR, Banu N, Gupta RM, Yadav RC. Enteral hyperalimentation in malnourished surgical patients. Indian J. Med. Res. 80, 339-346 (1984).
40. Flynn MB, Leightty FF. Preoperative outpatient nutritional support of patients with squamous cancer of the upper aerodigestive tract. Am. J. Surg. 154(4), 359-362 (1987).
41. Garibaldi RA. Prevention of intraoperative wound contamination with chlorhexidine shower and scrub. J. Hosp. Infect. 11 (Suppl.), B5-B9 (1988).
42. Paulson DS. Efficacy evaluation of a 4% chlorhexidine gluconate as a full-body shower wash. Am. J. Infect. Control 21 (4), 205-209 (1993).
43. Hayek LJ, Emerson JM, Gardner AM. A placebo-controlled trial of the effect of two preoperative baths or showers with chlorhexidine detergent on postoperative wound infection rates. J. Hosp. Infect. 10(2), 165-172 (1987).
44. Kaiser AB, Kernodle DS, Barg NL, Petracek MR. Influence of preoperative showers on staphylococcal skin colonization: a comparative trial of antiseptic skin cleansers. Ann. Thorac. Surg. 45(1), 35-38 (1988).
45. Lynch W, Davey PG, Malek M, Byrne DJ, Napier A. Cost-effectiveness analysis of the use of chlorhexidine detergent in preoperative whole-body disinfection in wound infection prophylaxis. J. Hosp. Infect. 21(3), 179-191 (1992).
46. Kretschmer T, Braun V, Richter HP. Neurosurgery without shaving: indications and results. Br. J. Neurosurg. 14 (4), 341-344 (2000).
47. Gil Z, Cohen JT, Spektor S, Fliss DM. The role of hair shaving in skull base surgery. Otolaryngol. Head Neck Surg. 128(1), 43-47 (2003).
48. Alexander JW, Fischer JE, Boyajian M, Palmquist J, Morris MJ. The influence of hair-removal methods on wound infections. Arch. Surg. 118(3), 347-352 (1983).
49. Sellick JA Jr, Stelmach M, Mylotte JM. Surveillance of surgical wound infections following open heart surgery. Infect. Control Hosp. Epidemiol. 12(10), 591-596 (1991).
50. Masterson TM, Rodeheaver GT Morgan RF, Edlich RF. Bacteriologic evaluation of electric clippers for surgical hair removal. Am. J. Surg. 148(3), 301-302 (1984).
51. Bernard HR, Cole WR. The prophylaxis of surgical infection: the effect of prophylactic antimicrobial drugs on the incidence of infection following potentially contaminated operations. Surgery 56, 151-157 (1964).
52. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am. J. Surg. 189(4), 395-404 (2005).
53. Barie PS, Eachempati SR. Surgical site infections. Surg. Clin. North Am. 85(6), 1115-1135 (2005).
54. Nichols RL, Condon RE, Barie PS. Antibiotic prophylaxis in surgery - 2005 and beyond. Surg. Infect. (Larchmt) 6(3), 349-361 (2005).
55. Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann. Allergy Asthma Immunol. 74(2), 167-170 (1995).
56. Stone HH, Hooper CA, Kolb LD, Geheber CE, Dawkins EJ. Antibiotic prophylaxis in gastric, biliary and colonic surgery. Ann. Surg. 184(4), 443-452 (1976).
57. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N. Engl. J. Med. 326(5), 281-286 (1992).
58. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin. Infect Dis. 38(12), 1706-1715 (2004).
59. Bratzler DW, Houck PM, Richards C et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch. Surg. 140(2), 174-182 (2005).
60. Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration. Ann. Thorac. Surg. 81 (1), 397-404 (2006).
61. Celdran A, Frieyro O, de la Pinta JC et al. The role of antibiotic prophylaxis on wound infection after mesh hernia repair under local anesthesia on an ambulatory basis. Hernia 8(1), 20-22 (2004).
62. Yerdel MA, Akin EB, Dolalan S et al. Effect of single-dose prophylactic ampicillin and sulbactam on wound infection after tension-free inguinal hernia repair with polypropylene mesh: the randomized, double-blind, prospective trial. Ann. Surg. 233(1), 26-33 (2001).
63. Lazorthes F, Chiotasso P, Massip P, Materre JP, Sarkissian M. Local antibiotic prophylaxis in inguinal hernia repair. Surg. Gynecol. Obstet. 175(6), 569-570 (1992).
64. Taylor EW, Byrne DJ, Leaper DJ, Karran SJ, Browne MK, Mitchell KJ. Antibiotic prophylaxis and open groin hernia repair. World J. Surg. 21 (8), 811-814 (1997).
65. Aufenacker TJ, Koelemay MJ, Gouma DJ, Simons MP. Systematic review and meta-analysis of the effectiveness of antibiotic prophylaxis in prevention of wound infection after mesh repair of abdominal wall hernia. Br. J. Surg. 93(1), 5-10 (2005).
66. Perez AR, Roxas MF, Hilvano SS. A randomized, double-blind, placebo-controlled trial to determine effectiveness of antibiotic prophylaxis for tension-free mesh herniorrhaphy. J. Am. Coll. Surg. 200(3), 393-397 (2005).
67. Aufenacker TJ, van Geldere D, van Mesdag T et al. The role of antibiotic prophylaxis in prevention of wound infection after Lichtenstein open mesh repair of primary inguinal hernia: a multicenter double-blind randomized controlled trial. Ann. Surg. 240(6), 955-960 (2004).
68. Sanchez-Manuel FJ, Seco-Gil JL. Antibiotic prophylaxis for hernia repair. Cochrane Database Syst. Rev. 4, CD003769 (2004).
69. Platt R, Zaleznik DF, Hopkins CC et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N. Engl. J. Med. 322(3), 153-160 (1990).
70. Gupta R, Sinnett D, Carpenter R, Preece PE, Royle GT. Antibiotic prophylaxis for post-operative wound infection in clean elective breast surgery. Eur. J. Surg. Oncol. 26(4), 363-366 (2000).
71. Platt R, Zucker JR, Zaleznik DF et al. Prophylaxis against wound infection following herniorrhaphy or breast surgery J. Infect. Dis. 166(3), 556-560 (1992).
72. Koc M, Zulfikaroglu B, Kece C, Ozalp N. A prospective randomized study of prophylactic antibiotics in elective laparoscopic cholecystectomy. Surg. Endosc. 17(11), 1716-1718 (2003).
73. Higgins A, London J, Charland S et al. Prophylactic antibiotics for elective laparoscopic cholecystectomy: are they necessary? Arch. Surg. 134(6), 611-614 (1999).
74. Simor AE, Ofner-Agostini M, Bryce E et al. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ 165(1), 21-26 (2001).
75. Fridkin SK, Hageman JC, Morrison M et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352(14), 1436-1444 (2005).
76. Mishaan AM, Mason EO Jr, Martinez-Aguilar G et al. Emergence of a predominant clone of community- acquired Staphylococcus aureus among children in Houston, Texas. Pediatr. Infect. Dis. J. 24(3), 201-206 (2005).
77. Bolon MK, Morlote M, Weber SG, Koplan B, Carmeli Y, Wright SB. Glycopeptides are no more effective than β-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin. Infect. Dis. 38(10), 1357-1363 (2004).
78. Chenoweth CE, DePestel DD, Prager RL. Are cephalosporins adequate for antimicrobial prophylaxis for cardiac surgery involving implants? Clin. Infect. Dis. 41(1), 122-123 (2005).
79. Zanetti G, Platt R. Antibiotic prophylaxis for cardiac surgery: does the past predict the future? Clin. Infect. Dis. 38(10), 1364-1366 (2004).
80. Muto CA, Jernigan JA, Ostrowsky BE et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect. Control Hosp. Epidemiol. 24(5), 362-386 (2003).
81. Khan OA, Weston VC, Scammell BE. Methicillin-resistant staphylococcus aureus incidence and outcome in patients with neck of femur fractures. J. Hosp. Infect. 51(3), 185-188 (2002).
82. Samad A, Banerjee D, Carbarns N, Ghosh S. Prevalence of methicillin-resistant Staphylococcus aureus colonization in surgical patients, on admission to a Welsh hospital. J. Hosp. Infect. 51(1), 43-46 (2002).
83. Melling AC, Ali B, Scott EM, Leaper DJ. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet 358(9285), 876-880 (2001).
84. Belda FJ, Aguilera L, Garcia de la Asuncion J et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 294(16), 2035-2042 (2005).
85. Greif R, Akca O, Horn EP, Kurz A, Sessler DI. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N. Engl. J. Med 342 (3), 161-167 (2000).
86. Pryor KO, Fahey TJ III, Lien CA, Goldstein PA. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA 291(1), 79-87 (2004).
87. Dellinger EP. Increasing inspired oxygen to decrease surgical site infection: time to shift the quality improvement research paradigm. JAMA 294(16), 2091-2092 (2005).
88. Rutala WA, Weber DJ. A review of single-use and reusable gowns and drapes in health care. Infect. Control Hosp. Epidemiol. 22(4), 248-257 (2001).
89. Blom A, Estela C, Bowker K, MacGowan A, Hardy JR. The passage of bacteria through surgical drapes. Ann. R Coll. Surg. Engl. 82(6), 405-407 (2000).
90. Werner HP, Hoborn J, Schon K, Petri E. Influence of drape permeability on wound contamination during mastectomy. Eur. J. Surg. 157(6-7), 379-383 (1991).
91. Moylan JA, Fitzpatrick KT, Davenport KE. Reducing wound infections. Improved gown and drape barrier performance. Arch. Surg. 122(2), 152-157 (1987).
92. Garibaldi RA, Maglio S, Lerer T, Becker D, Lyons R. Comparison of nonwoven and woven gown and drape fabric to prevent intraoperative wound contamination and postoperative infection. Am. J. Surg. 152(5), 505-509 (1986).
93. Moylan JA, Kennedy BV. The importance of gown and drape barriers in the prevention of wound infection. Surg. Gynecol. Obstet. 151(4), 465-470 (1980).
94. Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin. Microbiol. Rev. 17(4), 863-893 (2004).
95. Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm. Rep. 51 (RR-16), 1-45 (2002).
96. Edwards PS, Lipp A, Holmes A. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst. Rev. 3, CD003949 (2004).
97. Berry AR, Watt B, Goldacre MJ, Thomson JW, McNair TJ. A comparison of the use of povidone-iodine and chlorhexidine in the prophylaxis of postoperative wound infection. J. Hosp. Infect. 3(1), 55-63 (1982).
98. Dewan PA, Van Rij AM, Robinson RG, Skeggs GB, Fergus M. The use of an iodophor-impregnated plastic incise drape in abdominal surgery - a controlled clinical trial. Aust. NZ J. Surg. 57 (11). 859-863 (1987).
99. Lorenz RP, Botti JJ, Appelbaum PC, Bennett N. Skin preparation methods before cesarean section. A comparative study. J. Reprod. Med. 33(2), 202-204 (1988).
100. Segal CG, Anderson JJ. Preoperative skin preparation of cardiac patients. AORN J. 76(5), 821-828 (2002).
101. Alexander JW, Aerni S, Plettner JP. Development of a safe and effective one-minute preoperative skin preparation. Arch. Surg. 120(12), 1357-1361 (1985).
102. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338(8763), 339-343 (1991).
103. Hingst V, Juditzki I, Heeg P, Sonntag HG. Evaluation of the efficacy of surgical hand disinfection following a reduced application time of 3 instead of 5 min. J. Hosp. Infect. 20(2), 79-86 (1992).
104. O'Shaughnessy M, O'Malley VP, Corbett G, Given HF. Optimum duration of surgical scrub-time. Br. J. Surg. 78 (6), 685-686 (1991).
105. Wheelock SM, Lookinland S. Effect of surgical hand scrub time on subsequent bacterial growth. AORN J. 65(6), 1087-1092 (1997).
106. Parienti JJ, Thibon P, Heller R et al. Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates: a randomized equivalence study. JAMA 288(6), 722-727 (2002).
107. Pereira LJ, Lee GM, Wade KJ. An evaluation of five protocols for surgical handwashing in relation to skin condition and microbial counts. J. Hosp. Infect. 36(1), 49-65 (1997).
108. Deshmukh N, Kramer JW, Kjellberg SI. A comparison of 5-minute povidone - iodine scrub and 1-minute povidone - iodine scrub followed by alcohol foam. Mil. Med. 163(3), 145-147 (1998).
109. Bhende S, Spangler D. In vitro assessment of chlorhexidine gluconate-impregnated polyurethane foam antimicrobial dressing using zone of inhibition assays. Infect. Control Hosp. Epidemiol. 25(8), 664-667 (2004).
110. Hall LT, Bailes JE. Using Dermabond for wound closure in lumbar and cervical neurosurgical procedures. Neurosurgery 56(1 Suppl.), 147-150 (2005).
111. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann. Thorac. Surg. 67(2), 352-360 (1999).
112. Jarvis WR. Benchmarking for prevention: the Centers for Disease Control and Prevention's National Nosocomial Infections Surveillance (NNIS) system experience. Infection 31 (Suppl.), 244-248 (2003).
113. Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch. Surg. 137(10), 1096-1100 (2002).